These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 30553695)

  • 1. The efficacy, effectiveness, and immunogenicity of influenza vaccines in Africa: a systematic review.
    Lindsey BB; Armitage EP; Kampmann B; de Silva TI
    Lancet Infect Dis; 2019 Apr; 19(4):e110-e119. PubMed ID: 30553695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity and safety of different dosing schedules of trivalent inactivated influenza vaccine in pregnant women with HIV: a randomised controlled trial.
    Nunes MC; Cutland CL; Moultrie A; Jones S; Ortiz JR; Neuzil KM; Klugman KP; Simões EAF; Weinberg A; Madhi SA;
    Lancet HIV; 2020 Feb; 7(2):e91-e103. PubMed ID: 31911146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccines for preventing influenza in healthy adults.
    Demicheli V; Jefferson T; Ferroni E; Rivetti A; Di Pietrantonj C
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD001269. PubMed ID: 29388196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Technical guidelines for seasonal influenza vaccination in China (2022-2023)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) on Influenza Vaccination
    Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Oct; 56(10):1356-1386. PubMed ID: 36274602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial.
    Bernstein DI; Guptill J; Naficy A; Nachbagauer R; Berlanda-Scorza F; Feser J; Wilson PC; Solórzano A; Van der Wielen M; Walter EB; Albrecht RA; Buschle KN; Chen YQ; Claeys C; Dickey M; Dugan HL; Ermler ME; Freeman D; Gao M; Gast C; Guthmiller JJ; Hai R; Henry C; Lan LY; McNeal M; Palm AE; Shaw DG; Stamper CT; Sun W; Sutton V; Tepora ME; Wahid R; Wenzel H; Wohlbold TJ; Innis BL; García-Sastre A; Palese P; Krammer F
    Lancet Infect Dis; 2020 Jan; 20(1):80-91. PubMed ID: 31630990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccines for preventing influenza in the elderly.
    Demicheli V; Jefferson T; Di Pietrantonj C; Ferroni E; Thorning S; Thomas RE; Rivetti A
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD004876. PubMed ID: 29388197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influenza vaccines in immunosuppressed adults with cancer.
    Bitterman R; Eliakim-Raz N; Vinograd I; Zalmanovici Trestioreanu A; Leibovici L; Paul M
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD008983. PubMed ID: 29388675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness, immunogenicity, and safety of influenza vaccines with MF59 adjuvant in healthy people of different age groups: A systematic review and meta-analysis.
    Yang J; Zhang J; Han T; Liu C; Li X; Yan L; Yang B; Yang X
    Medicine (Baltimore); 2020 Feb; 99(7):e19095. PubMed ID: 32049815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influenza vaccination in the Americas: Progress and challenges after the 2009 A(H1N1) influenza pandemic.
    Ropero-Álvarez AM; El Omeiri N; Kurtis HJ; Danovaro-Holliday MC; Ruiz-Matus C
    Hum Vaccin Immunother; 2016 Aug; 12(8):2206-2214. PubMed ID: 27196006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine epidemiology: Its role in promoting sound immunization programs in Japan.
    Hirota Y; Ozasa K; Nakano T
    Vaccine; 2017 Aug; 35(36):4787-4790. PubMed ID: 28818469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of Serologic Assays in the Evaluation of Influenza Virus Infection Rates and Vaccine Efficacy in Pregnant Women: Report From Randomized Controlled Trials.
    Madhi SA; Nunes MC; Weinberg A; Kuwanda L; Hugo A; Jones S; van Niekerk N; Ortiz JR; Neuzil KM; Klugman KP; Simões EAF; Cutland CL;
    Clin Infect Dis; 2017 Jun; 64(12):1773-1779. PubMed ID: 28369198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influenza vaccine effectiveness in hospitalised Hong Kong children: Feasibility of estimates from routine surveillance data.
    Yeung KHT; Chan KCC; Chan PKS; Lam DSY; Sham PCO; Yau YS; Chan WH; Chiu WK; Ng KL; Ng DKK; Chan IMC; Nelson EAS
    Vaccine; 2018 Jun; 36(24):3477-3485. PubMed ID: 29739719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and effectiveness of seasonal and pandemic A (H1N1) 2009 influenza vaccines in low and middle income countries: a systematic review and meta-analysis.
    Breteler JK; Tam JS; Jit M; Ket JC; De Boer MR
    Vaccine; 2013 Oct; 31(45):5168-77. PubMed ID: 24012574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there a difference in the immune response, efficacy, effectiveness and safety of seasonal influenza vaccine in males and females? - A systematic review.
    Tadount F; Doyon-Plourde P; Rafferty E; MacDonald S; Sadarangani M; Quach C
    Vaccine; 2020 Jan; 38(3):444-459. PubMed ID: 31711676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccines for preventing influenza in healthy children.
    Jefferson T; Rivetti A; Di Pietrantonj C; Demicheli V
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD004879. PubMed ID: 29388195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seasonal influenza vaccine policy, use and effectiveness in the tropics and subtropics - a systematic literature review.
    Hirve S; Lambach P; Paget J; Vandemaele K; Fitzner J; Zhang W
    Influenza Other Respir Viruses; 2016 Jul; 10(4):254-67. PubMed ID: 26842617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An analysis of national target groups for monovalent 2009 pandemic influenza vaccine and trivalent seasonal influenza vaccines in 2009-10 and 2010-11.
    Ng S; Wu P; Nishiura H; Ip DK; Lee ES; Cowling BJ
    BMC Infect Dis; 2011 Aug; 11():230. PubMed ID: 21871096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity, safety, and effectiveness of seasonal influenza vaccination in patients with diabetes mellitus: A systematic review.
    Dos Santos G; Tahrat H; Bekkat-Berkani R
    Hum Vaccin Immunother; 2018; 14(8):1853-1866. PubMed ID: 29517396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal immunisation with trivalent inactivated influenza vaccine for prevention of influenza in infants in Mali: a prospective, active-controlled, observer-blind, randomised phase 4 trial.
    Tapia MD; Sow SO; Tamboura B; Tégueté I; Pasetti MF; Kodio M; Onwuchekwa U; Tennant SM; Blackwelder WC; Coulibaly F; Traoré A; Keita AM; Haidara FC; Diallo F; Doumbia M; Sanogo D; DeMatt E; Schluterman NH; Buchwald A; Kotloff KL; Chen WH; Orenstein EW; Orenstein LAV; Villanueva J; Bresee J; Treanor J; Levine MM
    Lancet Infect Dis; 2016 Sep; 16(9):1026-1035. PubMed ID: 27261067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.